New York, NY -- (SBWIRE) -- 12/26/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Celldex Therapeutics, Inc (NASDAQ:CLDX), DISH Network Corp (NASDAQ:DISH), Zions Bancorporation (NASDAQ:ZION), Amtrust Financial Services, Inc (NASDAQ:AFSI)
Celldex Therapeutics, Inc (NASDAQ:CLDX) showed a volume of 677,088.00 shares by the end of last trade whereas the average volume of the stock remained 2.40 million shares. The stock opened the session at $23.77 but then moved to $23.04. At that price, the stock showed a negative performance of -2.62%. Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127. CDX-110, is an immunotherapeutic vaccine that targets the tumor-specific molecule, epidermal growth factor receptor variant III (EGFRvIII).
Will CLDX Get Buyers Even After The Recent Rally? Find Out Here
DISH Network Corp (NASDAQ:DISH ) opened the session at $56.72 and closed the session at $57.25. The stock showed a positive/ performance of 1.15% in previous trading session. Traded with volume of 674,250.00 shares in the prior session and the average volume of the stock remained 3.02 million shares. DISH Network Corporation is a pay-television (TV) provider, with approximately 13.967 million customers across the United States as of December 31, 2011. The Company offers a range of local and national programming, featuring more national and local high definition (HD) channels than pay-TV providers. During the year ended December 31, 2011, DISH added approximately 2.576 million gross new subscribers. On April 26, 2011, the Company acquired Blockbuster, Inc.
For How Long DISH will fight for Profitability? Read This Trend Analysis report
Zions Bancorporation (NASDAQ:ZION) opened the session at $29.79 and closed the session at $29.84. The stock showed a positive performance of 0.40% in previous trading session. Traded with volume of 672,191.00 shares in the prior session and the average volume of the stock remained 2.03 million shares. The beta of the stock remained 2.07. Zions Bancorporation is a financial holding company. The Company focuses on providing community banking services by its core business lines of small and medium-sized business and corporate banking; commercial and residential development, construction and term lending; retail banking; treasury cash management and related products and services; residential mortgage; trust and wealth management, and investment activities.
Why Should Investors Buy ZION After The Recent Gain? Just Go Here and Find Out
Amtrust Financial Services, Inc (NASDAQ:AFSI) the stock advanced 1.85% and finished the session at $31.39. Traded with volume of 671,105.00 shares in the prior session and the average volume of the stock remained 1.28 million shares. The beta of the stock remained 0.70. Amtrust Financial Services, Inc. is a holding company. The Company is a multinational specialty property and casualty insurer focused on generating consistent underwriting profits. The Company operates in four business segments: small commercial business, specialty program and personal lines reinsurance. The Company transacts business through 11 insurance company subsidiaries: Technology Insurance Company, Inc. (TIC), Rochdale Insurance Company (RIC),
Will AFSI Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)